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The biological basis for the development of the cerebro-cerebellar structures required for posture and gait in humans is
poorly understood. We investigated a large consanguineous family from Turkey exhibiting an extremely rare phenotype
associated with quadrupedal locomotion, mental retardation, and cerebro-cerebellar hypoplasia, linked to a 7.1-Mb region
of homozygosity on chromosome 17p13.1–13.3. Diffusion weighted imaging and fiber tractography of the patients’ brains
revealed morphological abnormalities in the cerebellum and corpus callosum, in particular atrophy of superior, middle,
and inferior peduncles of the cerebellum. Structural magnetic resonance imaging showed additional morphometric ab-
normalities in several cortical areas, including the corpus callosum, precentral gyrus, and Brodmann areas BA6, BA44,
and BA45. Targeted sequencing of the entire homozygous region in three affected individuals and two obligate carriers
uncovered a private missense mutation, WDR81 p.P856L, which cosegregated with the condition in the extended family.
The mutation lies in a highly conserved region of WDR81, flanked by an N-terminal BEACH domain and C-terminal
WD40 beta-propeller domains. WDR81 is predicted to be a transmembrane protein. It is highly expressed in the cere-
bellum and corpus callosum, in particular in the Purkinje cell layer of the cerebellum. WDR81 represents the third gene,
after VLDLR and CA8, implicated in quadrupedal locomotion in humans.
[Supplemental material is available for this article.]
Developmental abnormalities of the cerebellum are a rare and ge-
netically heterogeneous group of disorders characterized by loss of
balance and coordination. Identification of the genes responsible
for these disorders provides mechanistic insights into the regulation
of neuronal development, differentiation, morphogenesis, migra-
tion, and organization (Fogel and Perlman 2007). These genes can
be identified by exploiting targeted genomic sequencing in com-
bination with linkage analysis and homozygosity mapping (Ropers
2007; Bilguvar et al. 2010). We applied this approach to the analysis
of cerebellar hypoplasia and quadrupedal locomotion in an ex-
tended consanguineous family from southern Turkey.
Multiple families have been reported with cerebellar ataxia,
mental retardation, and disequilibrium syndrome (CAMRQ ) (Tan
2006; Turkmen et al. 2006, 2009; Moheb et al. 2008; Ozcelik et al.
2008; Kolb et al. 2010). All the reported CAMRQ families are con-
sanguineous with recessive inheritance of their condition. Clinical
characteristics vary slightly among the families. In four families
from Turkey and Iran, the condition is due to homozygosity for
mutations in the VLDLR gene encoding the very low density lipo-
protein receptor (CAMRQ1 [MIM 224050]). Each of these four
families harbors a different VLDLR mutation. In a fifth family, from
Iraq, the condition is due to homozygosity for a missense mutation
in the CA8 gene encoding carbonic anhydrase VIII (CAMRQ3 [MIM
613227]). In Family B, the first family described in the literature
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and also referred to as Uner Tan syndrome (Tan 2006), homozy-
gosity mapping revealed a 7.1-Mb interval on chromosome 17p13,
containing 192 genes and at least 20 pseudogenes, that segre-
gates with the disease (CAMRQ2 [MIM 610185]) (Turkmen et al.
2006; Ozcelik et al. 2008). In order to identify the mutation re-
sponsible for CAMRQ2 in Family B, we targeted and fully se-
quenced the 7.1-Mb genomic interval and evaluated all variation
in the region.
Results
Description of the affected family
Family B came to medical attention because of the unusual form of
locomotion in five of the 19 siblings. A detailed clinical description,
including video recordings and genetic mapping, was published
elsewhere (Tan 2006; Turkmen et al. 2006; Ozcelik et al. 2008).
Pedigree analysis suggested autosomal recessive inheritance. Link-
age analysis and homozygosity mapping revealed a single locus on
chromosome 17p between D17S1866 and D17S960. Illumina 300
Duo v2 BeadChip SNP genotype data of two of the affected in-
dividuals (05-984 and 05-987) revealed a single 6.8-Mb homozy-
gous stretch between markers rs4617924–rs7338 (chr17: 114,669–
6,917,703) and confirmed that chromosome 17p is the only region
of interest (Supplemental Fig. 1).
The phenotype was further characterized by magnetic reso-
nance imaging (MRI) and morphometric analyses (Fig. 1). The
most dramatic morphological differences were significant re-
ductions in volume in the cerebellum and corpus callosum of the
patient’s brain (Fig. 1A). Both the cortex and the white matter of
the cerebellum were significantly smaller in the patients. In con-
trast, the volume occupied by the caudate nucleus was signifi-
cantly larger. Significant structural differences were also detected
in the motor areas precentral gyrus and BA6 (increased mean
curvature and gray matter volume) and motor speech areas pars
opercularis and pars triangularis (increased cortical thickness and
mean curvature) (Fig. 1B). A detailed account of the morphometric
analyses is presented in Supplemental Figure 2 and Supplemental
Table 1. Diffusion tensor imaging (DTI) and fiber tractography
revealed moderate to high atrophy in superior, middle, and in-
ferior cerebellar peduncles (Supplemental Fig. 3).
Targeted next-generation sequencing of the critical region
The critical region at chr17: 82,514–7,257,922 (hg19) was captured
by NimbleGen 385K microarrays and sequenced with 454 Life
Sciences (Roche) GS FLX in DNA of two of the affected individuals
(05-985, 05-987) and two of the unaffected obligate carrier parents
(05-981 father, 05-982 mother). An average of ;400 Mb, yielding
46.33 haploid coverage, was sequenced from the captured DNA of
each individual. An average of 79% of all reads from each sample
mapped to the target region, representing 1275-fold to 2247-fold
enrichment (Supplemental Table 2). On average, 99.4% of all targeted
bases were covered by at least four reads (Supplemental Table 3).
In a parallel experiment, the same region from the DNA of
another affected sibling (05-984) was captured with NimbleGen
HD2 2.1M sequence capture microarrays and sequenced on an
Illumina Genome Analyzer IIx. The captured region was enriched
123-fold, with 2.98 billion bases and 40.3 million reads obtained
and 28% of reads mapped to the targeted region; 99.6% of targeted
bases were covered by at least four reads. Combined sequence data
for the three affected siblings yielded at least a fourfold coverage of
99.78% of all coding base pairs, 95.32% of intronic and UTR base
pairs, and 91.36% of intergenic base pairs. The remaining 0.22% of
coding regions with less than fourfold coverage was analyzed by
Sanger sequencing (Supplemental Table 4).
With the 454 GS FLX platform, a total of 18,410 different
variants were detected at high confidence (defined as in Hedges
et al. 2009) in at least one sample (Supplemental Table 2). No ad-
ditional functional variants were detected with the Illumina se-
quencing platform. Comparison of the sequence data from both
platforms with Illumina 300 Duo v2 SNP genotype data indicated
that the alleles were detected with sensitivity and specificity >99%.
Heterozygous SNPs detected at the borders of the homozygous
blocks of the affected individuals narrowed the region of homo-
zygosity to 6.74 Mb (Supplemental Table 5). The Mendelian error
rate, an indicator of call errors (Hedges et al. 2009), was calculated
as 0.3%.
Of the 18,410 high-confidence variants, 17,281 were reported
by dbSNP. For each nonsynonymous SNP compatible with the
Mendelian transmission of the disease allele, the frequencies of
homozygotes for each allele were accessed from public databases.
With one exception, homozygosity at both alleles had been reported
in control populations. The one exception, rs55916885, was at a
nonconserved site and was predicted as tolerated by SIFT (Ng and
Henikoff 2001) and Polyphen-2 (Sunyaev et al. 2001). Based on
these observations, all previously reported nonsynonymous vari-
ants were excluded (Supplemental Table 6).
Of the 18,410 high-confidence variants, 1119 variants were
both novel vis-á-vis dbSNP132 and present in both the affected
siblings and their obligate carrier parents. These 1119 novel shared
variants were classified by genomic context: coding sequence or
flanking splice junctions (n = 20), 59 UTR or 39 UTR (n = 15),
intronic (n = 689), or intergenic (n = 395). The 20 variants in the
Figure 1. MRI-based morphological analysis of brain from affected and
unaffected individuals. (A) Midsagittal MRI scans of a healthy control in-
dividual (left) and affected relative from Family B (right). The highlighted
regions show areas where volumetric differences are readily visible: corpus
callosum (1), third ventricle (2), fourth ventricle (3), and cerebellum (4).
(B) Cortical regions with significant differences in morphometric param-
eters are displayed on a reference cortex, from lateral and medial view:
BA45 (5), BA44 (6), BA6 (7), precentral (8), superior temporal (9), superior
parietal (10), lateral occipital (11), fusiform (12), isthmus cingulated (13),
posterior cingulated (14), frontal pole (15), medial orbitofrontal (16), and
temporal pole (17). Additional details are provided in Supplemental
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coding sequence or flanking splice junctions were genotyped in the
family to evaluate cosegregation with the phenotype (Supplemental
Table 7). Genotypes of three missense variants were consistent with
the recessive inheritance of the disease allele in Family B: WDR81
p.P856L, MYBBP1A p.R671W, and ZNF594 p.L639F (Table 1). Of the
15 59/39 UTR variants, five cosegregated with the disease phenotype.
Therefore, they were carried to a more detailed analysis, including
evaluation of the protein interactions. None was found to interact
with previously identified genes with cerebellar phenotypes, in-
cluding CAMRQ-associated VLDLR and CA8 (Supplemental Table 8).
Identification of disease causing variant
MYBBP1A p.R671W could be excluded as the causal mutation for the
disorder of Family B based on the genotypes of controls (Supple-
mental Table 9). In 214 unrelated healthy controls (428 chromo-
somes), 50 of whom were sampled from the same region of Turkey as
Family B, 13 individuals were heterozygous for MYBBP1A p.R671W.
This carrier frequency yields an allele frequency of 0.016 and an
expected frequency of homozygotes of about one in 4000, far higher
than the frequency of CAMRQ2, which occurs in only one extended
family. In a second, independent series of 400 individuals of various
European and Middle Eastern ancestries, MYBBP1A was fully se-
quenced in the context of whole-exome sequencing. Of these 400
individuals, two were homozygous for MYBBP1A p.R671W. Neither
of these two homozygotes had any signs consistent with CAMRQ2.
MYBBP1A p.R671W was therefore excluded as the allele responsible
for the disorder of Family B.
ZNF594 p.L639F could be excluded as the causal mutation for
the disorder based on conservation considerations. Residue 639 of
ZNF594 is not well conserved: Two of 16 species sequenced have
phenylalanine (F) at the orthologous site, strongly suggesting that
phenylalanine at this site would also not be damaging in humans. A
negative GERP score (0.665) for the mutated nucleotide indicates
that this site is probably evolving neutrally (Davydov et al. 2010).
The variant is predicted as ‘‘benign’’ (PSIC score difference, 0.301) by
PolyPhen (Sunyaev et al. 2001) and ‘‘damaging low confidence’’
(SIFT score, 0.04) by SIFT (Supplemental Table 10; Ng and Henikoff
2001). In addition, the human ZNF594 gene harbors polymorphic
nonsense mutations at sites near the missense at L639F. ZNF594
p.E684X appeared in four of 118 Yoruban controls (rs114754534;
allele frequency, 0.034), and ZNF594 p.Q681X appeared in one of
120 CEU controls (rs116878311; allele frequency, 0.0083) in the
HapMap series.
In contrast, WDR81 p.P856L (Fig. 2A,B; Supplemental Fig. 4) is
both rare and alters a highly conserved site. This missense did not
appear in any of the 549 individuals of the control series. WDR81 is
a highly conserved protein throughout vertebrates, with no poly-
morphic stops in any sequenced species. In particular, proline at
residue 856 is completely conserved in all known sequences of the
WDR81 protein (Fig. 2C).
The extended genealogy of Family B revealed consanguinity
in several branches of the kindred (Fig. 2D), whose ancestors have
migrated from a village on the Syrian side of the border with Hatay,
Turkey, in the early 1950s. Approximately 240 individuals span-
ning seven generation could be ascertained. WDR81 p.P856L was
genotyped in 177 members of the kindred spanning five genera-
tions. A single union of heterozygous carriers, 05-981 3 05-982,
was observed whose children include the affected individuals of
this study. None of the 172 unaffected individuals in the kindred is
homozygous for WDR81 p.P856L. Genetic counseling is in prog-
ress for the 27 members of the family who are heterozygous carriers
of the mutation. The status of WDR81 was evaluated in two dif-
ferent cohorts of the patients with neurodevelopmental/cerebellar
phenotypes for whom the underlying genetic cause is still un-
known. The first cohort consisted of 750 patients with structural
cortical malformations or degenerative neurological disorders. By
using the whole-genome genotyping data based on Illumina Hu-
man 370 Duo or 610K Quad BeadChips, we did not identify any
patient with a cerebellar phenotype or ataxia phenotype to harbor
a homozygous interval ($2.5 cM) surrounding the WDR81 locus.
Exome sequencing of the same group did not reveal any muta-
tions, including compound heterozygous substitutions. In the
second cohort of 58 probands, 12 had cerebellar hypoplasia with or
without quadrupedal gait. No additional mutations in WDR81
were identified by Sanger sequencing of the entire coding regions.
Characterization of WDR81
WDR81 p.P856L at chr17: 1,630,820 (hg19) lies in exon 1 of
WDR81 isoform 1 (ENST00000409644, NM_001163809.1, NP_
001157281.1), the longest isoform of WDR81, containing 10
exons and encoding 1941 amino acids (Fig. 2A). Proline at this site
was present in all species analyzed (Fig. 2C), including the most
distantly related sequenced ortholog, the Tetraodon nigroviridis
WDR81 protein, which is 47.8% identical and 57.2% similar and
has a distance score of 0.76 compared with the human protein.
WDR81 p.P856L was predicted to be ‘‘damaging’’ (SIFT score, 0) by
SIFT (Ng and Henikoff 2001), ‘‘probably damaging’’ (PSIC score
difference, 2.724) by PolyPhen (Sunyaev et al. 2001), and ‘‘under
evolutionary constraint’’ (GERP score, 5.68) by GERP (Davydov
et al. 2010).
The function of WDR81 is unknown, but clues can be derived
from its structure. The conserved region of WDR81 that includes
P856 is flanked on the N-terminal side by a BEACH (Beige and
Chediak-Higashi) domain at amino acids 352–607. BEACH proteins
Table 1. Missense variants co-inherited with cerebellar hypoplasia and quadrupedal locomotion in Family Ba
No. and percentage of variant reads
Gene Position (hg19) Ref Var Effect 05-981b 05-982b 05-985c 05-987c
WDR81 chr17: 1,630,820 C T P856L 41 (51%) 33 (52%) 40 (97%) 53 (100%)
MYBBP1A chr17: 4,448,967 G A R671W 29 (52%) 21 (48%) 32 (97%) 29 (100%)
ZNF594 chr17: 5,085,637 G A L639F 39 (54%) 50 (56%) 38 (97%) 37 (100%)
Ref indicates reference nucleotide; Var, variant nucleotide.
aCoding regions, consensus splices-sites, and RNA genes.
bCarrier.
cAffected individual.
WDR81 is associated with CAMRQ2
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have been implicated in membrane trafficking (Wang et al. 2000),
synapse morphogenesis (Khodosh et al. 2006), and lysosomal axon
transport (Lim and Kraut 2009). A BEACH domain is the major
structural feature of neurobeachin, a scaffolding protein disrupted in
a patient with autism (Volders et al. 2011). WDR81 p.P856L lies in
a major facilitator superfamily (MFS) domain, a region characteristic
of solute carrier transport proteins (Saier et al. 1999). The C terminus
of WDR81 is composed of six WD-repeats that are likely constituents
of a beta-propeller. Based on analysis by TMpred (www.ch.embnet.
org/software/TMPRED_form.html), WDR81 is a transmembrane
protein with six membrane-spanning domains, the most N-terminal
at amino acids 45–66 and the other five at the C terminus of the
protein, between amino acids 980 and 1815 (Fig. 2A). Supporting
the likelihood that WDR81 is a transmembrane protein is the
observation that WDR81 transcript expression is increased in
membrane-associated RNA in contrast to cytoplasmic RNA (4.14
folds, P = 0.03, and 1.78 folds, P = 0.0002 in Gene Expression Om-
nibus [GEO] [http://www.ncbi.nlm.nih.gov/geo/] data set GSE4175)
(Diehn et al. 2006).
In order to assess a possible role for WDR81 in regulating
motor behavior, we evaluated the expression profiles of human
and mouse WDR81/Wdr81 isoform 1 in the brain. Human WDR81
isoform 1 transcript was expressed in all the tissues evaluated
(Supplemental Fig. 5). In particular, all the brain tissues were pos-
itive for the transcript, with highest levels of expression in the
cerebellum and corpus callosum (Fig. 3A). In the mouse brain at
post-partum day P7, Wdr81 expression was observed in Purkinje
cell layer in the cerebellum (Fig. 3B,C). The cerebellum is a crucial
regulatory center for motor function.
We examined the expression of WDR81 in the context of ex-
pression profiles of the early embryonic mouse brain (GSE8091)
(Hartl et al. 2008). Differentially expressed genes within the day
groups were filtered (one-way ANOVA test Bonferroni-corrected P <
0.001, n = 3611). From these profiles, we identified the subset of
genes whose expression was highly correlated with that of WDR81
(R > 0.95, n = 670) and then used DAVID tools (Huang et al. 2009) to
evaluate the predicted functions of this subset of genes. The subset
of genes coexpressed with WDR81 was enriched for those involved
in neuronal differentiation and neuronal projection, axonogenesis,
and cell morphogenesis (Bonferroni-corrected P-values 2.3 3
1011, 1.3 3 109, and 3.7 3 109, respectively). Among the genes
coexpressed with WDR81 were those encoding prion protein,
doublecortin (responsible for lissencephaly), and L1CAM (re-
sponsible for MASA syndrome) (Supplemental Table 11). WDR81
is not coexpressed with VLDLR and CA8, raising the possibility
that WDR81 represents a different developmental regulatory
pathway.
Discussion
The identification of genes responsible for human disease has been
greatly facilitated with new technologies, particularly the targeted
enrichment of the genome by solution capture, followed by geno-
mic sequencing (Bilguvar et al. 2010). Despite these advances,
demonstrating the causality for a mutation in the absence of two or
more independent cases remains a challenge. This is particularly
true when multiple variants, none of them with obvious effect on
protein function, cosegregate with the phenotype in the family; the
candidate gene encodes a previously uncharacterized protein with
multiple isoforms, of which the critical mutation is on only one; and
the candidate mutation is a missense. However, unique families and
uncharacterized proteins exist, and precisely because of this reason,
it becomes imperative to fully exploit genetics and genomics ap-
proaches to distinguish the causative mutation.
We describe here the discovery of a mutation associated with
an extremely rare and genetically heterogeneous autosomal re-
cessive phenotype in a unique consanguineous family (Tan 2006).
The putative causative mutation could be distinguished from pre-
viously unknown rare polymorphisms in the same genomic region
by analysis of conservation at all candidate variant sites, by the
presence of polymorphic stops in the critical region of another
candidate gene, and by genotyping ethnically matched unaffected
individuals who would not be expected to carry homozygous mu-
tations at the mutant site. We conclude that the WDR81 p.P856L
mutation is the cause of cerebellar hypoplasia associated with qua-
drupedal locomotion in Family B.
WDR81 is an uncharacterized gene. It shows similarity with
a host of genes, including NSMAF (neutral sphyngomyelinase ac-
tivation associated factor), NBEA (neurobeachin), and LYST (lyso-
somal trafficking regulator). The LYST gene contains HEAT/ARM
repeats, a BEACH domain, and seven WD40 repeats (Ward et al.
2000). Nearly all reported LYST mutations result in protein trun-
cation and lead to Chediak-Higashi syndrome (CHS), which is
characterized by accumulation of giant intracellular vesicles lead-
ing to defects in the immune and blood systems (Rudelius et al.
2006). Two patients with missense LYST mutations have been
reported (Karim et al. 2002). Interestingly, these patients presented
with neurological symptoms without immunological involvement.
The LystIng3618/LystIng3618 mutant mouse harbors a missense mu-
tation in the WD40 domain. Purkinje cell degeneration accom-
panied by age-dependent impairment of motor coordination without
Figure 3. Expression pattern of WDR81 in brain. (A) Expression in hu-
man brain with highest levels in cerebellum and corpus callosum. (B) In
situ hybridization of mouse embryonic brain revealing increased expres-
sion of Wdr81 in purkinje cells and molecular layer of cerebellum. (C ) No
hybridization was observed with the sense probe. (ML) Molecular layer,
(GL) granular layer.
WDR81 is associated with CAMRQ2
Genome Research 1999
www.genome.org
 Cold Spring Harbor Laboratory Press on November 26, 2012 - Published by genome.cshlp.orgDownloaded from 
signs of lysosomal deficiency in immunological organs were charac-
teristics of these animals (Rudelius et al. 2006).
Expression of WDR81 at high levels in the human cerebellum
and corpus callosum and in the Purkinje cell layer of the mouse
cerebellum is consistent with our observations of major structural
abnormalities in these regions of the brain of affected individuals.
Together, these observations suggest a possible role for WDR81 in
motor behavior. Further work will be required to understand the
normal biological function of WDR81 and the role of the mutation
in causing cerebellar hypoplasia and quadrupedal locomotion.
Genomic analysis of Family B demonstrates that WDR81 is highly
likely to be critical to these developmental processes.
Methods
Human subjects
The institutional review boards of Bilkent, Hacettepe, Baskent,
and Cukurova Universities approved the study (decisions: BEK02,
28.08.2008; TBK08/4, 22.04.2008; KA07/47, 02.04.2007; and 21/3,
08.11.2005, respectively). Written informed consent, prepared
according to the guidelines of the Ministry of Health in Turkey, was
obtained from all family members and control group subjects prior
to the study. A total of 18 subjects participated in MRI scans. Six of
them were from Family B, including four affected siblings (05-984,
05-986, 05-987, 05-988), one normal female sibling homozygous
for the wild-type allele of the WDR81 p.P856L variant (10-033),
and their carrier father (05-981). The remaining 14 participants
were age- and sex-matched healthy controls. The two male pa-
tients (age, mean 6 SD = 37.00 6 4.24) were matched to seven male
controls (age, mean 6 SD = 35.14 6 5.76), and the two female
patients (age, mean 6 SD=27.00 6 4.24) were matched to seven
female controls (age, mean 6 SD = 28.57 6 3.64). Family B mem-
bers were scanned under sedation. For the healthy controls, no
sedation was performed. Sedation was achieved by initial admin-
istration of midazolam (2 mg per subject), which was followed by
propofol (120 mg) and fentanyl (50 mcg) administration in-
travenously. Hypnosis level was adjusted by 20 mg injections
of propofol approximately every 10 min to eliminate somatic re-
sponses such as slight movements. Blood oxygen level and heart
rate were monitored during the entire procedure. Eyelash reflexes
were absent at all times. Neuromuscular blockade was not used.
Next-generation sequencing
NimbleGen 385K microarrays were produced to capture the criti-
cal region at chr17: 82,514–7,257,922 (hg19) using 7464 unique
probes with a total probe length of 4,853,455 bp. Sequence Search
and Alignment by Hashing Algorithm (SSAHA) (Ning et al. 2001)
was used to determine probe uniqueness by NimbleGen (Roche
NimbleGen). Sequence capture was conducted by the NimbleGen
facility using 25 mg of input DNA. Captured DNA samples were
subjected to standard sample preparation procedures for 454 GS
FLX sequencing with Titanium series reagents. Four full 454 GS
FLX runs were conducted for two affected individuals (05-985, 05-
987) and their unaffected obligate carrier parents (05-981 father,
05-982 mother). Sequence data were initially mapped to human
genome reference sequence and annotated using the GSMapper
software package (Roche). Fold enrichment of the target region was
calculated with the formula +REMTrm/STrm: +RMG/SG as de-
scribed previously (REMTrm, number of reads mapped to target
region; STrm, size of target region; RMG, number of reads mapped
outside of the target region; SG, size of human genome) (Rehman
et al. 2010). Variants were identified with ALLDiff and more strin-
gent HCDiff approaches (Hedges et al. 2009). Annotation of variants
was made by GSMapper software using the refGene table of the
University of California, Santa Cruz (UCSC) Genome Browser
(Fujita et al. 2010). Ensembl 62 genome annotation data for hg19
human genome assembly were extracted using the BIOMART data-
mining tool for further analysis of intronic and intergenic variants
in terms of hypothetical genes and splicing variants (Flicek et al.
2011). Novel variants were reported based on the SNPs included
in the reference SNP database. For Illumina sequencing, a total of
6,184,539-bp-long unique probes were designed to target a 9-Mb
genomic region spanning the disease locus (chr17:0–9,059,276;
hg19) using a custom NimbleGen HD2 2.1M sequence capture
microarray. Another affected individual was sequenced with the
Illumina Genome Analyzer IIx. Illumina sequence data were map-
ped to the reference genome using MAQ tools (Li et al. 2008), and
single nucleotide variants were determined with Samtools (Li et al.
2009). To determine indels, data were mapped with BWA (Li and
Durbin 2010) and analyzed with Samtools. Sequence data were
visually analyzed using the Integrative Genomics Viewer (IGV)
(Robinson et al. 2011).
Array based genotyping
We conducted Illumina 300 Duo v2 BeadChip for two affected
individuals (05-984, 05-987) according to the manufacturer’s rec-
ommendations (Illumina). The image data were normalized, and
the genotypes were called using data analysis software (Bead Stu-
dio, Illumina). Sex, inbreeding, and sibship were confirmed.
The Mendelian compatibility of sequence variants was analyzed
with PLINK (Purcell et al. 2007).
DNA sequencing
Confirmation of novel variants identified by next-generation se-
quencing was done with conventional capillary sequencing. The
Primer3 software (Rozen and Skaletsky 2000) was used to design
PCR primers for the amplification of candidate variants (Supple-
mental Table 12). Products were analyzed via gel electrophoresis
and were sequenced using forward and reverse primers on an ABI
3130 XL capillary sequencing instrument (Applied Biosystems).
Sanger sequence trace files were analyzed with the CLCBio Main
Workbench software package (CLCBio Inc.).
Population screening
To distinguish the disease-causing variant from novel polymor-
phisms, a population screening approach was conducted for each
candidate variant. Allele-specific PCR (AS-PCR) and restriction frag-
ment length polymorphism (RFLP) analyses were performed (Sup-
plemental Table 12) on 1098 chromosomes from a healthy control
population. In addition, the first-, second-, and third-degree rela-
tives of the affected family, amounting to 177 individuals, were
sampled for genotype analysis. Sanger sequencing was performed to
confirm all of the variants detected in the normal population using
the above-mentioned methods. Racial distribution of the control
group was 100% Caucasian, including 22% from southeastern Turkey.
Quantitative real-time RT-PCR analysis of WDR81 expression
First-strand cDNA was prepared from multi-tissue RNA panels
(Clontech: 636567, 636643; Agilent: 540007, 540117, 540137,
540157, 540053, 540005, 540143, 540135) with RevertAid kit and
random hexamer primers (Fermentas; K1622) after DNase I (Fer-
mentas; EN0521) digestion. The PCR primers located in exon 1
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ware (Supplemental Table 13; Rozen and Skaletsky 2000). SYBR
Green real-time PCR were realized according to standard protocols
(BioRad; 170-8882) with 100% PCR efficiency. Each assay included
minus RT and nontemplate controls. Ct values were normalized to
GAPDH as an internal control. The data were analyzed using the
Pfaffl method (Pfaffl 2001).
In situ hybridization
In order to examine the specific expression pattern of Wdr81 gene
in the mouse brain, probes that contain the mutated region in
human patients were prepared by PCR amplification of the region
from mouse genomic DNA and subsequent cloning into plasmids.
The riboprobes were synthesized by using Dig-labeled NTPs, and
in situ hybridization experiments were performed as described
(Tekinay et al. 2009). The Animal Ethics Committee of Bilkent
University approved procedures for the tissue extraction and for in
situ hybridization tests. Animals were group housed in a 12-h dark,
12-h light cycle. Embryo and P7 brain sections were prepared as
described (Gong et al. 2003). Twenty-micrometer sagittal sections
were taken with a cryostat (Leica). The antisense probe was prepared
by PCR amplification from the mouse genomic DNA and sub-
sequent cloning into pCR4-TOPO vector (Invitrogen). A modified
version of pSK vector was used for cloning the sense probe of the
same region. Digoxigenin (Dig)-labeled riboprobe was transcribed
using Dig-NTP in the transcription reaction. Riboprobes were pu-
rified with Mini Quick Spin DNA columns (Roche) prior to hy-
bridization. Sections were incubated at 60°C overnight in hybrid-
ization buffer containing 50% formamide, 53 SSC, 53 Denhardt’s
reagent, 50 mg/mL heparin, 500 mg/mL herring sperm DNA, and
250 mg/mL yeast tRNA. Hybridized sections were washed for 90 min
with 50% formamide and 23 SSC at 60°C. Probes were detected
with anti-Dig Fab fragments conjugated to alkaline phosphatase
and NBT/BCIP substrate mixture (Tekinay et al. 2009).
Bioinformatics analyses
Homozygosity mapping analysis was performed using Homo-
zygosityMapper software (Seelow et al. 2009). SIFT (Ng and Henikoff
2001) and PolyPhen (Sunyaev et al. 2001) tools were used to pre-
dict the functional impact of the variants. Genomic Evolutionary
Rate Profiling (GERP) scores for each variant were obtained from
the UCSC Genome Browser allHg19RS_BW track (Davydov et al.
2010). The PFAM protein domain search module of CLCMain
Workbench V5.0 (CLCBio, Inc.) and ScanProsite (Gattiker et al.
2002) tools were used to predict domains and possible effects of the
variant on protein product. Membrane spanning domains were
predicted using TMpred software (www.ch.embnet.org/software/
TMPRED_form.html). Homology searches were performed with
CLCMain Workbench using appropriate modules (reference se-
quence accession codes for WDR81 orthologs are Ailuropoda
melanoleuca, XP_002918082; Callithrix jacchus, XP_002747874; Danio
rerio, XP_001921778; Equus caballus, XP_001502383; Gallus gallus,
XP_415806; Monodelphis domestica, XP_001371487; Mus musculus,
NP_620400; Oryctolagus cuniculus, XP_002718930; Pan troglodytes,
XP_523527; Pongo abelii, XP_002826860; Rattus norvegicus, NP_
001127832; Sus scrofa, XP_003131868; Taeniopygia guttata, XP_
002194363; Tetraodon nigroviridis, CAG08933; Xenopus [Silurana]
tropicalis, XP_002937192). Published microarray data sets of E9.5,
E11.5, and E13.5 mouse brain tissue (GSE8091) were downloaded
from the GEO database (http://www.ncbi.nlm.nih.gov/projects/
geo/query/acc.cgi) (Hartl et al. 2008) and processed with GeneSpring
GX V11.1 software (Agilent Technologies). Data sets were grouped
within day groups, and standard quality control and filtering
analysis were performed (http://www.chem.agilent.com/cag/bsp/
products/gsgx/manuals/GeneSpring-manual.pdf). Differentially ex-
pressed genes within the day groups were filtered using a one-way
ANOVA test (Bonferroni-corrected P < 0.001). Genes that corre-
lated with Wdr81 (R = 0.95  1.0) were obtained using the ‘‘Find
Similar Entity Lists’’ module of the software. Functional annota-
tion clustering was performed using the obtained gene list by
DAVID tools (Huang et al. 2009). WDR81 differential expression in the
GEO data sets was further investigated using the NextBio System,
a web-based data-mining engine (Kupershmidt et al. 2010), and the
GSE4175 (Diehn et al. 2006) data set was selected as a significant dif-
ference in membrane-associated RNA versus cytoplasmic RNA com-
parisons. Ensembl identifiers of the candidate genes and transcripts
are as follows: WDR81 [ENSG00000167716; ENST00000409644],
MYBBP1A [ENSG00000132382; ENST00000254718], and ZNF594
[ENSG00000180626; ENST00000399604].
MRI data acquisition and structural analysis procedures
MRI data were acquired using a three Tesla scanner (Magnetom
Trio, Siemens AG) with a 12-channel phase-array head coil. A high-
resolution T1-weighted three-dimensional (3D) anatomical-vol-
ume scan was acquired for each participant (single-shot turbo
flash; voxel size = 1 3 1 3 1 mm3; repetition time [TR] = 2600 msec;
echo time[TE] = 3.02 msec; flip angle = 8°; field of view [FOV] = 256 3
224 mm2; slice orientation = sagittal; phase encode direction =
anterior-posterior; number of slices = 176; acceleration factor
[GRAPPA] = 2). DTI data were acquired using a single-shot spin-echo
EPI with a parallel imaging technique GRAPPA (acceleration factor
2). The sequence was performed with 30 gradient directions, and the
diffusion weighting b-factor was set to 800 sec/mm2 (TR, 6400
msec; TE, 88 msec; in-plane resolution, 1 mm 3 1 mm; slice thick-
ness, 3.0 mm; 50 transverse slices; base resolution, 128 3 128).
Structural analyses were performed with the Freesurfer image anal-
ysis package (http://surfer.nmr.mgh.harvard.edu/). The analyses
involved intensity normalization, removal of nonbrain tissue, sub-
cortical segmentation (Fischl et al. 2002), and identification of the
white matter/gray matter boundary upon which cortical re-
construction and volumetric parcellation were performed. The
cortex was then registered to a spherical atlas and parceled into units
according to the gyral and sulcal structure based on the Desikan-
Kilinay Atlas (Desikan et al. 2006) and the Destrieux Atlas (Destrieux
et al. 2010). Next, using the same software, we performed mor-
phometric analyses of cortical thickness, mean curvature, surface
area, and volume for each unit of parcellation and computed the
group differences. Significant differences between the groups are
determined using two-tailed unpaired t-tests at an alpha level of
0.05. Fiber tracking was performed in MedINRIA (Toussaint et al.
2007). Fibers with FA < 0.3 were excluded from the analysis. Region
of interests (ROIs) were drawn manually over cross-sections of su-
perior, middle, and inferior cerebellar peduncles, using the MRI
Atlas of Human White Matter as a reference (Oishi et al. 2010). ROIs
were drawn at approximately corresponding locations for the pa-
tients and healthy controls. Fiber tracts were first limited to pass
through these ROIs and were then subsequently refined using a re-
cursive tracking technique (Toussaint et al. 2007). T1-weighted
images were coregistered with DWI data using FSL (Smith et al.
2004; Woolrich et al. 2009). Final tracts were manually overlaid onto
high-resolution T1-weighted images for illustration purposes.
Data access
Sequence data of the homozygous region has been deposited at the
DNA Data Bank of Japan (DDBJ; http://www.ddbj.nig.ac.jp/) under
accession no. DRA000432. SNP genotype data have been deposited
at the European Genome-Phenome Archive (EGA; http://www.
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ebi.ac.uk/ega/), which is hosted at the EBI, under accession no.
EGAS00000000099.
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